8 August, 2025Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
6 August, 2025Pi-Cardia’s ShortCut™ becomes First Leaflet Modification Technology to receive CMS NTAP for Valve-in-Valve TAVR
5 August, 2025Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
23 July, 2025TISSIUM announces U.S. commercial launch of COAPTIUM® Connect and strategic governance evolution
17 July, 2025One Biosciences announces €15 Million Series A financing to advance clinical single cell profiling